meta_pixel
Tapesearch Logo
Log in
Cato Podcast

Descheduling Is Preferable to Rescheduling Cannabis

Cato Podcast

Cato Institute

Government, Policy, 424708, Immigration, Defense, Peace, Politics, News, Cato, Libertarian, News Commentary, Markets

4.5979 Ratings

🗓️ 1 May 2024

⏱️ 11 minutes

🧾️ Download transcript

Summary

The DEA is likely to change its federal designation for cannabis in the coming months. It's a good sign for research and for the ability of Americans to receive medical treatments involving the plant, but descheduling and ending federal prohibition is still a worthy goal. Jeff Singer explains.

Hosted on Acast. See acast.com/privacy for more information.

Transcript

Click on a timestamp to play from that location

0:00.0

This is the Kato Daily Podcast for Wednesday, May 1st,

0:07.0

2004. I'm Caleb Brown. It seems likely that DEA will reschedule cannabis,

0:12.4

removing it from a category of drugs deemed by the

0:15.2

agency to have low medical value and a high potential for abuse.

0:19.7

That will make it easier for Americans to receive cannabis for medical reasons and allow more research.

0:25.7

But that move still represents a federal regulatory agency making big decisions about your

0:31.0

ability to seek certain medical treatment.

0:34.0

Cato's Jeff Singer comments.

0:36.0

This is, I guess, an uncomfortable position in a way for libertarians who have a particular view of how the government ought to proceed with

0:45.7

cannabis, this is not the end of cannabis prohibition. Is that right? That's correct

0:52.4

it just means that if you get a permission slip

0:56.1

from a licensed health care practitioner, licensed by the state,

1:00.4

then you can get some cannabis for medicinal uses and otherwise if you want to

1:07.6

recreational use cannabis it's still against the law you can still get arrested

1:11.8

you can still go to prison.

1:13.2

Of course, the states and feds differ in how they treat cannabis, but one thing is important to note here,

1:21.6

Schedule 1 is a determination made by a federal regulatory agency that a particular chemical or in this case a plant has low potential for therapy. a made as I said by a regulatory agency.

1:44.0

Well in fact the regulatory agency is a law enforcement agency.

1:48.0

What I call cops practicing medicine.

1:50.0

The Drug Enforcement Administration is empowered to add or remove drugs from a schedule that it creates of controlled substances,

1:59.0

substances that it oversees, you know, the consumption and distribution of. It relies on advice from the

2:07.7

Department of Health and Human Services and the Food and Drug Administration, which

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Cato Institute, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Cato Institute and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.